Results 21 to 30 of about 913,703 (307)

Ocular adverse events in PD-1 and PD-L1 inhibitors

Journal for ImmunoTherapy of Cancer, 2021
Background Programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) inhibitors can cause unique immune-related adverse effects due to non-specific immunological activation.
James Murray, Howard Streicher, Elad Sharon, LeAnne Young, Shanda Finnigan, H Nida Sen, Helen X Chen   +6 more
doaj   +1 more source

Vårdskador vid omvårdnad : en studie av patienters, anhörigas och vårdgivares anmälningar [PDF]

, 2017
Background: Patient safety has, over the last decades, been increasingly established as an important global issue. Patient safety is jeopardized by for example adverse events and most of the current evidence on adverse events originates from hospitals,
Andersson, Åsa
core   +1 more source

Analysis of Centruroides (Scorpion) Immune F(ab’)2 (Equine) administration by slow intravenous push

Toxicology Communications, 2023
Scorpion envenomation is a common emergency department presentation in Arizona and antivenom is often administered . This study evaluates the safety of Centruroides (Scorpion) Immune F(ab’)2 (Equine) administered as a single-vial-serial dosing strategy ...
Clinton Peter, Spencer Kruggel, Aimee Mishler, Bikash Bhattarai, Dan Quan   +4 more
doaj   +1 more source

Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events [PDF]

, 2009
Epidemiological evidence has suggested a link between beta(2)-agonists and increased asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta(2)-agonists are safe ...
Altman, Anonymous, Arthurs, Aubier, Bailey, Barnes, Bateman, Bateman, Bateman, Bateman, Bateman, Bateman, Bateman, Beach, Bons, Boushey, Boushey, Boushey, Bousquet, Bousquet, Bousquet, Briggs, Busse, Busse, Castle, Cates, Cates, Cates Christopher, Clark, Clark, Clark, Clark, Clark, Cordier, Ducharme, Edin, Giembycz, Godard, Greenstone, Ind, Jarjour, Juniper, Kavuru, Koenig, Koopmans, Lipworth, Lundbäck, Malone, Murray, Nathan, Nathan, Nelson, Nelson, Ni Chroinin, Ni Chroinin, Noord, Pauwels, Pauwels, Pauwels, Pearce, Pearlman, Pearlman, Pedersen, Pedersen, Pederson, Rojas, Rooklin, Salpeter, Sears, Shapiro, Strand, Wallin, Walters, Walters, Weinstein   +74 more
core   +1 more source

Safety, efficacy and biomarkers analysis of mesenchymal stromal cells therapy in ARDS: a systematic review and meta-analysis based on phase I and II RCTs

Stem Cell Research & Therapy, 2022
Background Mesenchymal stromal cells (MSCs) therapy for acute respiratory distress syndrome (ARDS) is an emerging treatment, but most of the current trials of MSCs stay in the animal experimental stage, and the safety and efficacy of MSCs in clinical ...
Jianbao Wang, Fenbin Luo, Ye Suo, Yuxin Zheng, Kaikai Chen, Deyuan You, Yuqi Liu   +6 more
doaj   +1 more source

A prospective cohort study comparing the reactogenicity of trivalent influenza vaccine in pregnant and non-pregnant women [PDF]

, 2015
Background: Influenza vaccination during pregnancy can prevent serious illness in expectant mothers and provide protection to newborns; however, historically uptake has been limited due to a number of factors, including safety concerns.
A Legge, AK Regan, AL Naleway, Annette K Regan, C Yuet Sheung Yuen, CA Peschken, Caroline Talbot, Christopher C Blyth, D Carcione, DB Fell, Donna B Mak, EO Kharbanda, Geoffrey Shellam, IH Russo, JD Nordin, JD Nordin, JR Russo, KE Wiley, Lauren Tracey, M Henninger, MJ Bartlett, P Duclos, Paul V Effler, Peter C Richmond, PL Moro, PV Effler, RA Bednarczyk, SE Haberg, SE Taksdal, World Health Organisation   +29 more
core   +2 more sources

Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients

Journal for ImmunoTherapy of Cancer, 2019
Following publication of the original article [1], the authors reported an error in their listed affiliations.
Bin Zhao, Hong Zhao, Jiaxin Zhao
doaj   +1 more source

COVID-19 vaccine safety monitoring in Republic of Korea from February 26, 2021 to October 31, 2021 [PDF]

Osong Public Health and Research Perspectives, 2021
Objectives This study aimed to present data on reported adverse events following coronavirus disease 2019 (COVID-19) vaccination in Republic of Korea from February 26 to October 31, 2021, and to determine whether any significant patterns emerged from an ...
Insob Hwang, Kyeongeun Park, Tae Eun Kim, Yunhyung Kwon, Yeon-Kyeng Lee   +4 more
doaj   +1 more source

COVID-19 vaccine safety monitoring in the Republic of Korea: February 26, 2021 to April 30, 2021 [PDF]

Osong Public Health and Research Perspectives, 2021
Objectives On February 26, 2021, coronavirus disease 2019 (COVID-19) vaccination was started for high-priority groups based on the recommendation of the Advisory Committee on Immunization Practices with 2 available COVID-19 vaccines (AstraZeneca and ...
Hyun-kyung Oh, Eun Kyeong Kim, Insob Hwang, Tae Eun Kim, Yeon-kyeong Lee, Eunju Lee, Yeon-Kyeng Lee   +6 more
doaj   +1 more source

Adverse events and safety issues associated with physical activity and exercise for adults with osteoporosis and osteopenia: A systematic review of observational studies and an updated review of interventional studies [PDF]

, 2018
Objectives: We conducted a systematic review to identify adverse effects of physical activity and/or exercise for adults with osteoporosis/osteopenia. We synthesised evidence from observational studies, and updated three previously published systematic ...
Clark, Emma M., Cox, Matthew, Gibbons, Nicola, James, Laura, Kunutsor, Setor K., Leyland, Sarah, Skelton, Dawn A, Whitney, Julie   +7 more
core   +3 more sources